Home › Research › Biomarkers
Metallic Woodpile Nanostructures for Femtomolar Sensing of Alzheimer's Neurofilament Lights
Kim K, Lee GR, Kim M, Lim H, Jung YS, Park CB.. ACS nano, 2020-07-29
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Alzheimer's disease (AD), the most common age-related neurodegenerative disorder, accompanies a massive degradation of neurons including axonal injury. Being an axonal neuron-specific protein, neurofilament light (NfL) is a blood biomarker that reflects the neurodegeneration in AD, but no attempt has been made yet to develop sensing platforms that target NfLs in blood serum or plasma. Here, we report three-dimensional cross-stacked Pt nanowire arrays for the ultrasensitive photoelectrochemical (PEC) detection of NfLs. We constructed a woodpile-like Pt nanowire array (PtWP)-based biocathode by printing multilayer Pt nanowire arrays in an orthogonal configuration and conjugating them with NfL-specific DA2 antibodies. According to our collective electrochemical analyses, the five-layered PtWP electrode modified with DA2 antibodies exhibited high oxygen reduction activities due to the large electrochemical active surface area and the effective electron transfer properties. We have combined the DA2-PtWP biocathode with a water-oxidizing, iron oxyhydroxide-deposited bismuth vanadate (FeOOH/BiVO 4 ) photoanode to assemble a bias-free PEC detection system. Powered by a white-light-emitting diode, the unbiased PEC platform accurately recognizes NfLs in blood plasma with the limit-of-detection of 38.2 fg/mL and limit-of-quantification of 853 fg/mL, which is 40 times lower than the NfL levels in AD patients' blood.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Kim, K., Lee, G. R., Kim, M., Lim, H., Jung, Y. S., & Park, C. B. (2020). Metallic Woodpile Nanostructures for Femtomolar Sensing of Alzheimer's Neurofilament Lights. ACS nano. https://doi.org/10.1021/acsnano.0c04053
Vancouver
Kim K, Lee GR, Kim M, Lim H, Jung YS, Park CB. Metallic Woodpile Nanostructures for Femtomolar Sensing of Alzheimer's Neurofilament Lights. ACS nano. 2020. doi:10.1021/acsnano.0c04053. PMID: 32706577.
BibTeX
@article{kim2020-32706577,
author = {Kim, K. and Lee, G. R. and Kim, M. and Lim, H. and Jung, Y. S. and Park, C. B.},
title = {{Metallic Woodpile Nanostructures for Femtomolar Sensing of Alzheimer's Neurofilament Lights}},
journal = {ACS nano},
year = {2020},
doi = {10.1021/acsnano.0c04053},
pmid = {32706577},
url = {https://doi.org/10.1021/acsnano.0c04053}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Here, we report three-dimensional cross-stacked Pt nanowire arrays for the ultrasensitive photoelectrochemical (PEC) detection of NfLs.
- We constructed a woodpile-like Pt nanowire array (PtWP)-based biocathode by printing multilayer Pt nanowire arrays in an orthogonal configuration and conjugating them with NfL-specific DA2 antibodies.
- According to our collective electrochemical analyses, the five-layered PtWP electrode modified with DA2 antibodies exhibited high oxygen reduction activities due to the large electrochemical active surface area and the effective electron transfer properties.
- We have combined the DA2-PtWP biocathode with a water-oxidizing, iron oxyhydroxide-deposited bismuth vanadate (FeOOH/BiVO 4 ) photoanode to assemble a bias-free PEC detection system.
- Powered by a white-light-emitting diode, the unbiased PEC platform accurately recognizes NfLs in blood plasma with the limit-of-detection of 38.2 fg/mL and limit-of-quantification of 853 fg/mL, which is 40 times lower than the NfL levels in AD patients' blood.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Evidence strengthLow
How this study scored 38/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 22 of the 58 points we could judge it on, which is 38 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (ACS nano) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 32706577) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 22 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 22 of the 58 points we could judge it on is 38 out of 100. |
| Total | 38 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also in Biomarkers
136 studies in the library are filed under Biomarkers with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Biomarkers hub.